title: An institutional policy on the right to benefit from the commercialization of human biological material.
authors.forename: E D
authors.initials: ED
authors.lastname: Prentice
authors.forename: J C
authors.initials: JC
authors.lastname: Wiltse
authors.forename: J G
authors.initials: JG
authors.lastname: Sharp
authors.forename: D L
authors.initials: DL
authors.lastname: Antonson
mesh_terms: D035843:Biomedical Research; D002460:Cell Line; D003132:Commerce; D046508:Culture Techniques; D028741:Ethics Committees, Clinical; D028744:Ethics Committees, Research; D035082:Federal Government; D033161:Government Regulation; D018594:Human Body; D006801:Humans; D007258:Informed Consent; D010067:Ownership; D028701:Patient Rights; D035842:Research Subjects; D014019:Tissue Donors; D009927:Tissue and Organ Procurement; D014481:United States